Skip to content
Menu

CVRx, Inc. CVRX

Full chart Compare
Set alert

Price alert · CVRX

All alert types
0.50 USD -0.03 (-5.99%)

Regular-session close

0.52 +0.02 +3.79%

After hours · Nov 20, 4:00 PM ET

0.4972 Day range 0.569
0.4972 52-week range 10.28
YTD
-92.94%
1 year
-94.31%

5D -0.0118 (-1.73%)

0.60000.65000.7000ThuFriMonTueWed0.6702
Market cap
14.27M
Revenue (ttm)
47.26M
Profit margin
-123.75%
EPS (ttm)
-2.00
Shares out
24.26M
Forward P/E
-5.84
YTD return
-92.94%
1-year return
-94.31%
50-day average
12.92
Volume
519.85K
Avg volume
747.91K
Open
0.5287
Previous close
0.5329
Day's range
0.4972 – 0.569
52-week range
0.4972 – 10.28
Beta
1.11
Analysts
Buy
Price target
18.17 (+3526.1%)

Key statistics

200-day average
11.61
Enterprise value
244.11M
Price / sales
6.42
Price / book
4.64
Revenue growth
27.20%
Free cash flow
-21.40M
Total cash
100.16M
Total debt
50.44M
Return on equity
-79.02%
Short % of float
12.35%

Fundamental scorecard

8 of 25 checks passed on CVRX’s reported financials

ValueGrowthProfitabilityHealthDividend

8of 25 checks passed

  • Value 2 of 5
  • Growth 2 of 5
  • Profitability 1 of 5
  • Financial health 3 of 5
  • Dividend 0 of 5

Statements to Sep 30, 2026.

Financials — quick view

All financials
CVRX Revenue — quarterly 13.83M
CVRX Net income — quarterly -14.16M
CVRX EPS — quarterly -0.52

Earnings

CVRX recent earnings
Report dateQuarter endingEPS estimateEPS reportedSurpriseSurprise %
Jan 23, 2025Dec 1, 2024-0.38———
Oct 29, 2024Sep 1, 2024-0.45-0.57-0.12-26.67%
Jul 29, 2024Jun 1, 2024-0.51———
Jul 29, 2024Jun 1, 2024-0.51-0.65-0.14-27.45%
Apr 30, 2024Mar 1, 2024-0.53———
Apr 30, 2024Mar 1, 2024-0.53-1.04-0.51-96.23%

Upgrades / downgrades

CVRX analyst upgrades and downgrades
DateFirmActionFromTo
Dec 9, 2024Canaccord GenuitymainBuyBuy
Nov 4, 2024Craig-HallummainBuyBuy
Oct 30, 2024Lake StreetmainBuyBuy
Oct 30, 2024Canaccord GenuitymainBuyBuy
Oct 30, 2024Piper SandlerreitOverweightOverweight
Oct 23, 2024Cantor FitzgeraldreitOverweightOverweight

About CVRx, Inc.

CVRx, Inc., a commercial-stage medical device company, focuses on developing, manufacturing, and commercializing neuromodulation solutions for patients with cardiovascular diseases. The company offers Barostim, a neuromodulation device indicated to improve symptoms for patients with heart failure with reduced ejection fraction or systolic heart failure. It sells its products through direct sales force, as well as sales agents and independent distributors in the United States, Germany, and internationally. The company was incorporated in 2000 and is headquartered in Minneapolis, Minnesota.

Sector
Healthcare
Industry
Medical Devices
Country
United States
Website
cvrx.com

News

Your note

Sign in to keep a note on CVRX — it syncs with the Stock Master app.

Insider holders

CVRX insider holders
InsiderRelationLatest transactionDateShares held
BEHBAHANI ALIDirectorConversion of Exercise of derivative securityDec 13, 2023316
GALLE LIZOfficerConversion of Exercise of derivative securityOct 15, 2023778
HYKES KEVINChief Executive OfficerPurchaseAug 4, 202430,000
JOHNSON & JOHNSON INNOVATION - JJDC, INC.Beneficial Owner of more than 10% of a Class of SecurityConversion of Exercise of derivative securityFeb 28, 20240
OASHEIM JAREDChief Financial OfficerConversion of Exercise of derivative securitySep 17, 202315,447
PALMER CRAIG EOfficerConversion of Exercise of derivative securityMar 24, 20241,229

Institution ownership

CVRX institution ownership
Holder% heldSharesValueReported
Johnson & Johnson16.91%4,103,43051.29MSep 29, 2024
NEA Management Company, LLC9.77%2,370,54229.63MSep 29, 2024
Blackrock Inc.3.75%909,42311.37MSep 29, 2024
Vanguard Group Inc3.40%824,29010.30MSep 29, 2024
Parkman Healthcare Partners LLC2.81%682,8978.54MSep 29, 2024
Schonfeld Strategic Advisors Llc2.25%545,3006.82MSep 29, 2024

Fund ownership

CVRX fund ownership
Holder% heldSharesValueReported
Vanguard Total Stock Market Index Fund2.24%544,3486.80MSep 29, 2024
iShares Russell 2000 ETF1.40%338,5364.23MOct 30, 2024
College Retirement Equities Fund-Stock Account0.69%167,8402.10MSep 29, 2024
Vanguard Extended Market Index Fund0.68%165,8022.07MSep 29, 2024
Trust for Professional Managers-Mairs & Power Small Cap Fund0.59%142,4561.78MSep 29, 2024
Fidelity Small Cap Index Fund0.56%136,8851.71MAug 30, 2024